Both overexpression of Gal-9 on gastric cancer cells and expression of TIM-3 on immune cells correlates negatively with poor outcomes in cancer patients (93) and lead to an increase in granulocytic myeloid-derived suppressor cells that inhibit immune responses impacting tumor growth (94). Here, LGALS9 is linked to neoplasm.